Novartis Vaccines and Diagnostics - Region North America re-org

Discussion in 'Novartis' started by Anonymous, Jan 4, 2012 at 4:57 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Crown jewel of pandemic readiness. Hilarious.
     

  2. Anonymous

    Anonymous Guest

    I am currently holding an offer in IT department with Novartis Vaccine division. Looking at all the comments in this thread, I am really worried and concerned about whether I should join or not.
    Any guidance would be appreciated.
     
  3. Anonymous

    Anonymous Guest

    It's better than Unemployment. Not much.
     
  4. Anonymous

    Anonymous Guest

    Please don't tell me this is real. No one in their right mind would join when layoffs are looming. IT will be cut right off the bat. GSK has their own IT. This has to be a joke.
     
  5. Anonymous

    Anonymous Guest

    Gowd, no bigger joke than this place has ever been - "Menveo = Billion $ franchise", "Bexzero, game changer".

    You sir, are hypocrisy, wrapped in irony covered in a stinking turd.
     
  6. Anonymous

    Anonymous Guest


    Partially agree to that statement. However, there is a very weak pro and a very strong con with that.

    Yes, Novartis Vaccines is still getting job applications from external, but ONLY from individuals currently without a job, re-entering the job market, newcomers, etc..
    Offering jobs now to those applicants is just to fill up the many open positions for a few weeks/months by making the impression that the organization is still functioning well, which is not, of course.

    Well trained, experienced staff, currently employed at other companies, would never apply to NVx now!
     
  7. Anonymous

    Anonymous Guest

    Fascade
     
  8. Anonymous

    Anonymous Guest

    We are getting all the recent layoffs and who would-have-been layoffs from a large CRO in the area. There is no where else to go in this field except NVX, unless you have good enough connections to get further than a phone interview or you happen to fill another company's diversity quota needs.
     
  9. Anonymous

    Anonymous Guest


    Sure, but everyone now accepting a new job with NVX is doing no good to her/his mid-term/long-term career aspirations, because this will be considered by every other future employer as a weakness, i.e. little/no confidence in its own capabilities, being inflexible, having very little knowledge about the business in which applying for, and so on and on.
    In other words, it is always better not to take a new job with NVX now than actually accepting such an offer, no matter how well paid it might be for now. Please, consider this as advice by someone having 20+ years pharmaceutical industry experience.
     
  10. Anonymous

    Anonymous Guest

    That is true and on principle I do not disagree, but when pharma jobs are increasingly becoming scarce and the pool of available qualified labor is intense, then you have to take what you can get. Not everyone working and applying in pharma is hovering 50 years old or older, childless and have most big expenses in life already out of the way to be unemployed for a year or longer. Its a way of thinking that existed in this field back in the employment glory days of 1996-2009, give or take a year or two in either direction.
     
  11. Anonymous

    Anonymous Guest

    And with the fundamental changes to the healthcare market those days are gone forever.
     
  12. Anonymous

    Anonymous Guest


    Potentially true for North America and perhaps to a lesser extent for Western Europe. But, do not forget that with ageing societies (market expansion) and with less of qualified grads entering the job market this will be re-adjusted. One reason why big pharma is keeping/establishing R&D sites nearby important, big universities (e.g. Boston/Cambridge) is because of fear not getting enough people on board in the coming years. In the future there will be little reason for the hundred of thousands of Asians/Indians and South Americans to enter the previously considered prime job markets in North America (and Western Europe)...
     
  13. Anonymous

    Anonymous Guest

    The aging of the societies will drive healthcare spending of course but Wetern Europe already has the formula for the US. They get the same healthcare outcomes at half the price. The US simply has too much healthcare. We use too much and what we use costs too much. That is now changing and it doesn't take research to do that.

    There will always be research but the vast majority of research in the US over the last 39 years was spent ooh products that simply got companies a place at the table to get a part of that over spending. Most treatments offerd little or no benefit over those already on the market and with the structure of payments and spending did little or nothing on prices.

    It is very obvious that there will be little or no spending on research on these types of products in the future as there will be no market for them in the US.
     
  14. Anonymous

    Anonymous Guest

    But, if we take market results as an indication Vaccines Research and Development never came up with a product that significantly impacted public health?
     
  15. Anonymous

    Anonymous Guest

    OMG, Jenny McCarthy, is that you?
     
  16. Anonymous

    Anonymous Guest

    No, I am not Jenny McCarthy. BTW, there are at least 25 Jenny McCarthys in the Greater NY area...:))

    Far more important on this CP site is the ongoing discussion what comes next with NVx, don't you agree?
    As said before, NVx business (or what at least had been considered to be a business) is now turning into a fascade, and that is what GSK should increasingly fear, too. The sooner the day 1, the better it will be for them, no question.
    It will take quite substantial efforts to get rid of all those recent Heads of Very important...s....
    Imagine, in the still-headquarter in Switzerland it will take up to 10 months to actually get people out through the main gate...unbelievable, isn't it?
     
  17. Anonymous

    Anonymous Guest

    I wonder what GSK will do with all the new Heads of very important sh$t. Will they check CVs? And then what, once the discover Heads of shi$ have 3 years of industry experience since their internships? Seems like they can't demote them for lack of experience since they will see they have stellar performance reviews from the Global Heads of sh@t.
     
  18. Anonymous

    Anonymous Guest

    3 years since internship and already a dept. Head? Probably all over, but you are referring to Holly Springs more so than the other units, right? One person comes to mind with that exact description.
     
  19. Anonymous

    Anonymous Guest

    So what if they're head of something? From my understanding, if they get absorbed by GSK, they will not take any pay cut. And even if they are eventually let go, they have stock options that will vest based on a higher salary and fatter %. Their severance will also be bigger. They will laugh their way to the bank. They will not despair or feel miserable like many of you here.
     
  20. Anonymous

    Anonymous Guest

    This whole thing is one big shit show. A joke. And the pace at which people are madly running around here is insane. You would think that we all have a future ahead of us.